Literature DB >> 7375085

Acquired hyperopia with choroidal folds.

R E Kalina, R P Mills.   

Abstract

Six healthy adults suddenly developed a unilateral or bilateral hyperopic shift in refractive error of up to 6 diopters. Fundi of affected eyes showed typical choroidal folds. Visual acuity was improved to normal or near normal by plus lenses, and refraction and fundus appearance have remained stable for up to 23 years. The benign syndrome of acquired hyperopia with choroidal folds deserves emphasis in order to spare patients from unnecessary and potentially hazardous neurosurgical or orbital investigation.

Entities:  

Mesh:

Year:  1980        PMID: 7375085     DOI: 10.1016/s0161-6420(80)35279-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

Review 1.  Chorioretinal folds: a proposed diagnostic algorithm.

Authors:  Alessandro Bagnis; Carlo Alberto Cutolo; Guido Corallo; Donatella Musetti; Massimo Nicolò; Carlo Enrico Traverso
Journal:  Int Ophthalmol       Date:  2019-02-20       Impact factor: 2.031

2.  Retinal and Choroidal Folds in Papilledema.

Authors:  Patrick A Sibony; Mark J Kupersmith; Steven E Feldon; Jui-Kai Wang; Mona Garvin
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

3.  Refractive change in thyroid eye disease (a neglected clinical sign).

Authors:  S Chandrasekaran; C Petsoglou; F A Billson; D Selva; R Ghabrial
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

4.  Acquired choroidal folds: a sign of idiopathic intracranial hypertension.

Authors:  Jacó Lavinsky; Daniel Lavinsky; Fabio Lavinsky; André Frutuoso
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-22       Impact factor: 3.535

5.  Post-operative optical coherence tomography angiography features of chorioretinal folds resulting from pleomorphic adenoma of the lacrimal gland (PALG) of orbit- a case report.

Authors:  Nan-Ni Chen; Chien-Hsiung Lai; Tsai Yueh-Ju; Chau -Yin Chen
Journal:  BMC Ophthalmol       Date:  2020-12-10       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.